Skip to content

Efficacy and Safety of the Hcoil Deep TMS for the Treatment of Cannabis Addiction

Status
UNKNOWN
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00543036
Enrollment
Unknown
Registered
2007-10-12
Start date
Unknown
Completion date
Unknown
Last updated
2007-10-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Marijuana Abuse

Keywords

Cannabis, Addiction, Craving, TMS

Brief summary

Evaluation of efficacy and safety of H-coil deep transcranial magnetic stimulation 9 week treatment trial for cannabis addiction as assessed by measures of drug intake and craving.

Interventions

Sponsors

Shalvata Mental Health Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
21 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Male and Female, aged 21-70 years, who meet DSM-IV TR diagnostic criteria for cannabis abuse and are motivated to quit cannabis use as assessed in the screening visit and gave their written informed consent to participate in the study.

Exclusion criteria

* History of a primary major psychiatric other then cannabis abuse, or cognitive disorder according to DSM-IV TR criteria. * Hamilton depression scale rated 25 and above (moderate to severe depression) * Current alcohol or other substance abuse or dependence * Alcohol or other substance abuse or dependence during the last 12 months before recruitment. * History of or evidence of significant brain malformation,neoplasm, head injury, cerebral vascular events,neurodegenerative disorder or brain surgery. * Severe somatic co-morbidity * History of seizures Cardiac pace maker or other electronic implants Pregnancy and lactation

Countries

Israel

Contacts

Primary ContactZiv Carmel, M.D.
zivca@clalit.org.il+972-9-7478570

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026